-
中文名稱:人膠原蛋白三螺旋重復(fù)包含蛋白1(CTHRC1)酶聯(lián)免疫試劑盒
-
貨號:CSB-EL006162HU
-
規(guī)格:96T/48T
-
價格:¥3600/¥2500
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:
The human collagen triple helix repeat-containing protein 1 (CTHRC1) ELISA Kit is used to quantitatively measure human CTHRC1 concentrations in serum, plasma, or tissue homogenates. It performs well in important characteristics, including sensitivity and specificity. This assay is based on the sandwich ELISA mechanism and enzyme-substrate chromogenic reaction. The solution color develops proportionally to the amount of CTHRC1 in the sample. And the intensity of the color can be measured at 450 nm via a microplate reader.
CTHRC1 is a secreted extracellular matrix (ECM) protein transiently expressed in the repair process after arterial injury and myocardial infarction, thus regulating collagen matrix deposition and cell migration and promoting tissue repair through the TGF-β signaling pathway. It is also involved in some pathophysiological processes, including increasing bone mass, preventing myelination, and reversing collagen synthesis in many tumor cells. Increased expression of CTHRC1 is associated with tumorigenesis, proliferation, invasion, and metastasis in various types of human cancer, including gastric cancer, pancreatic cancer, breast cancer, colorectal cancer, non-small-cell lung carcinoma, and melanoma.
-
別名:Collagen triple helix repeat containing 1 ELISA Kit; Collagen triple helix repeat containing protein 1 ELISA Kit; Collagen triple helix repeat-containing protein 1 ELISA Kit; CTHR1_HUMAN ELISA Kit; Cthrc1 ELISA Kit; NMTC1 protein ELISA Kit; Protein NMTC1 ELISA Kit
-
縮寫:CTHRC1
-
Uniprot No.:
-
種屬:Homo sapiens (Human)
-
樣本類型:serum, plasma, tissue homogenates
-
檢測范圍:6.25 ng/mL-400 ng/mL
-
靈敏度:1.56 ng/mL
-
反應(yīng)時間:1-5h
-
樣本體積:50-100ul
-
檢測波長:450 nm
-
研究領(lǐng)域:Cancer
-
測定原理:quantitative
-
測定方法:Sandwich
-
精密度:
Intra-assay Precision (Precision within an assay): CV%<8% Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV%<10% Three samples of known concentration were tested in twenty assays to assess. -
線性度:
To assess the linearity of the assay, samples were spiked with high concentrations of human CTHRC1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. Sample Serum(n=4) 1:1 Average % 85 Range % 80-89 1:2 Average % 91 Range % 88-96 1:4 Average % 95 Range % 91-99 1:8 Average % 93 Range % 87-96 -
回收率:
The recovery of human CTHRC1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. Sample Type Average % Recovery Range Serum (n=5) 99 92-104 EDTA plasma (n=4) 92 89-98 -
標準曲線:
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. ng/ml OD1 OD2 Average Corrected 400 2.445 2.372 2.409 2.217 200 1.872 1.950 1.911 1.719 100 1.401 1.418 1.410 1.218 50 0.892 0.863 0.878 0.686 25 0.585 0.544 0.565 0.373 12.5 0.403 0.389 0.396 0.204 6.25 0.292 0.279 0.286 0.094 0 0.194 0.190 0.192 -
數(shù)據(jù)處理:
-
貨期:3-5 working days
引用文獻
- CTHRC1 mediates IL?1β?induced apoptosis in chondrocytes via JNK1/2 signaling Zhang Q,International journal of molecular medicine,2023
- CTHRC1 as a novel biomarker in the diagnosis of cervical squamous cell carcinoma Xu, Guangxu.et al,Int J Clin Exp Pathol,2018
- CTHRC1 mediates IL Qi Zhang.et al,Int J Mol Med,2018
相關(guān)產(chǎn)品
靶點詳情
-
功能:May act as a negative regulator of collagen matrix deposition.
-
基因功能參考文獻:
- CTHRC1 serves as a pro-metastatic gene that contributes to NSCLC invasion and metastasis, which are mediated by upregulated MMP7 and MMP9 expression. Targeting CTHRC1 may be beneficial for inhibiting NSCLC metastasis. PMID: 29631554
- High Collagen Triple Helix Repeat Containing 1 Expression is associated with Osteosarcoma. PMID: 29970438
- E6/E7-p53-POU2F1-CTHRC1 axis promotes cervical cancer cell invasion and metastasis PMID: 28303973
- IL-1beta and CTHRC1 are upregulated in patients with Osteoarthritis. PMID: 29393342
- CTHRC1 interacts with integrin beta3 and accelerates the FAK phosphorylation to promote ovarian cancer cell adhesion, migration and invasion in vitro and in vivo. PMID: 29021002
- CTHRC1 plays a pivotal role in a great many fields, including increases bone mass, prevents myelination, reverses collagen synthesis in keloid fibroblasts, and increases fibroblast-like synoviocytes migration speed and abundant production of arthritic pannus in rheumatoid arthritis PMID: 28901303
- CTHRC1, negatively regulated by miR-30c, promoted cell proliferation, invasion and migration and suppressed cell apoptosis in breast cancer, which might be by activating GSK-3beta/beta-catenin signaling and inhibiting Bax/Caspase-9/Caspase-3 signaling respectively. PMID: 28697793
- Our data suggest that CTHRC1 may act as an oncogenic driver in progression and metastasis of ESCC, and may serve as a potential biomarker for prognosis and personalized therapy. PMID: 28645305
- The negative and sensitivity-predictive values of CTHRC1 staining were excellent for both lymph node and peritoneal metastases. PMID: 27870703
- High CTHRC1 expression is associated with metastatic melanomas. PMID: 26918341
- CTHRC1 was established as a novel marker of activated synoviocytes in murine experimental arthritis and rheumatoid arthritis PMID: 27430622
- ANOS1 and its co-expression partner, CTHRC1, promote the development and metastasis of colorectal cancer. PMID: 28854193
- Expression of CTHRC1 was significantly higher in Wilms' tumor compared to the expression in the adjacent non-cancerous tissues. High tumor expression of CTHRC1 was associated with tumor size, clinical stage, histopathological type, and vascular invasion/metastasis. Patients with high CTHRC1 expression also exhibited a shorter survival. PMID: 27230801
- CTHRC1 expression is significantly upregulated in human masticatory mucosa during wound healing. PMID: 28005267
- CTHRC1 downregulation inhibited proliferation. PMID: 28281968
- The knockdown of CTHRC1 exerts inhibitory effects on the proliferation and migration ability of glioblastoma cells. PMID: 28277194
- CTHRC1 may play a role in the progression of ovarian cancer. PMID: 27779718
- this study shows that the serum CTHRC1 level was significantly higher in the influenza A virus infection patients than in the healthy individuals; the influenza A virus non-structural protein NS1 upregulates the expression of CTHRC1 protein PMID: 27718266
- Gene expression levels of three randomly selected DEGs, VCAN, COL5A1 and KCNJ16, were examined using RT-PCR in 10 ATC samples.. angiogenesis was activated by the high expression of CTHRC1, VCAN and POSTN, providing necessary nutrition for tumor cells PMID: 27599582
- increased CTHRC1 expression is associated with advanced TNM stage, increased LN metastasis and tumor size, and decreased OS and DFS, indicating that CTHRC1 may be a biomarker for prognosis of cancer patients PMID: 27323076
- High CTHRC1 expression is associated with Osteosarcoma. PMID: 27043295
- Authors showed that ectopic transfection of CTHRC1 in EOC cells up-regulated the expression of EMT markers such as N-cadherin and vimentin, and EMT-associated transcriptional factor Snail. PMID: 26452130
- CTHRC1 is secreted both by colorectal epithelia cells and stromal fibroblasts. CTHRC1 overexpression promotes colorectal cancer cell migration, invasion and proliferation in vitro. PMID: 26722469
- determined the mRNA and protein expression of CTHRC1 in oral squamous cell carcinoma and evaluated the clinical and prognostic impact of CTHRC1 overexpression PMID: 26664254
- CTHRC1 has a novel role in viral infection. PMID: 26180054
- HBV facilitates HCC development through activating the oncoprotein CTHRC1. PMID: 25263696
- CTHRC1 was overexpressed in human non-small cell lung cancer tissues and non-small cell lung cancer cell lines at the protein and mRNA level. PMID: 25238260
- let-7b may directly target Cthrc1 and function as a tumor suppressor gene in gastric cancer. PMID: 25510669
- CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCP-Rho signaling. PMID: 24726140
- Cthrc1 overexpression was associated with non-small cell lung cancers. PMID: 25139095
- Cthrc1 is a pituitary hormone with significantly elevated levels in subjects carrying variant alleles of the melanocortin-1 receptor as wells as in patients with inflammatory conditions. PMID: 24945147
- CTHRC1 has the potential to be a new biomarker for the aggressive hepatocellular carcinoma PMID: 24841500
- CTHRC1 expression is elevated in human colon cancer cell lines and clinical specimens, and promotes cancer cell invasivity through ERK-dependent induction of MMP9 expression. PMID: 24504172
- Studied CTHRC1 expression in human breast cancer tissue. A significant increase of CTHRC1 mRNA expression was seen in breast cancer tissue compared to the normal tissue from the same patients using RT-PCR and real-time PCR. PMID: 23658133
- Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis. PMID: 23922981
- Rs35500845 in the CTHRC1 gene was associated with Paget's disease of bone in the French-Canadian population. PMID: 24370779
- high Cthrc1 expression was an independent prognostic factor for both overall survival and disease-free survival of patients with gastric carcinoma PMID: 24746208
- Data suggest that in oral squamous cell carcinoma (OSCC), dysregulation of canonical Wnt signaling and DPAGT1-dependent N-glycosylation induces CTHRC1, thereby driving OSCC cell migration and tumor spread. PMID: 23703614
- this is the first demonstration of Cthrc1 as a marker of the severity of the disease progression in the dystrophic muscles. PMID: 23274062
- the results of our study suggest that increased expression of CTHRC1 is associated with peritoneal carcinomatosis in Colorectal cancer patients PMID: 23359115
- CTHRC1 has a role in pancreatic cancer progression and metastasis by regulating migration and adhesion activities of cancer cells. PMID: 23222813
- Data indicate that the upregulated expression of collagen triple helix repeat containing 1 (CTHRC1) in gastric carcinogenesis contributes to tumor cell invasion and metastasis. PMID: 22590977
- Three major genes, MSR1, ASCC1, and CTHRC1 were associated with Barrett esophagus/esophageal adenocarcinoma PMID: 21791690
- CTHRC1 is transiently expressed in the arterial wall in response to injury where it may contribute to vascular remodeling by limiting collagen matrix deposition and promoting cell migration. PMID: 15618538
- Aberrant expression of CTHRC1 is widely present in human solid cancers and seems to be associated with cancer tissue invasion and metastasis. PMID: 16778098
- Intracellular localization of Cthrc1 characterizes differentiated smooth muscle. PMID: 18467647
顯示更多
收起更多
-
相關(guān)疾?。?/div>Barrett esophagus (BE)亞細胞定位:Secreted, extracellular space, extracellular matrix.組織特異性:Isoform 1 is expressed in calcified atherosclerotic plaque and chondrocyte-like cells.數(shù)據(jù)庫鏈接:
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-